In the context of CKD-associated sarcopenia, IL6 and TNFα have been studied most extensively [173,174], and they provide strong evidence that inflammation is a potent contributor to skeletal muscle atrophy in CKD (Figure 2) [47,175]. Here, IL6 is linked to chronic kidney disease.